Correlation Between ACADIA Pharmaceuticals and Cabaletta Bio

Can any of the company-specific risk be diversified away by investing in both ACADIA Pharmaceuticals and Cabaletta Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACADIA Pharmaceuticals and Cabaletta Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ACADIA Pharmaceuticals and Cabaletta Bio, you can compare the effects of market volatilities on ACADIA Pharmaceuticals and Cabaletta Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACADIA Pharmaceuticals with a short position of Cabaletta Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACADIA Pharmaceuticals and Cabaletta Bio.

Diversification Opportunities for ACADIA Pharmaceuticals and Cabaletta Bio

-0.43

Correlation Coefficient

ACADIA Pharmaceuticals  Cabaletta Bio

Very good diversification

The 3 months correlation between ACADIA and Cabaletta is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding ACADIA Pharmaceuticals and Cabaletta Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabaletta Bio and ACADIA Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACADIA Pharmaceuticals are associated (or correlated) with Cabaletta Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabaletta Bio has no effect on the direction of ACADIA Pharmaceuticals i.e., ACADIA Pharmaceuticals and Cabaletta Bio go up and down completely randomly.

Pair Corralation between ACADIA Pharmaceuticals and Cabaletta Bio

Given the investment horizon of 90 days ACADIA Pharmaceuticals is expected to generate 9.49 times less return on investment than Cabaletta Bio. But when comparing it to its historical volatility, ACADIA Pharmaceuticals is 3.91 times less risky than Cabaletta Bio. It trades about 0.06 of its potential returns per unit of risk. Cabaletta Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  187.00  in Cabaletta Bio on September 23, 2024 and sell it today you would earn a total of  51.00  from holding Cabaletta Bio or generate 27.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ACADIA Pharmaceuticals  vs.  Cabaletta Bio

ACADIA Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ACADIA Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, ACADIA Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Cabaletta Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cabaletta Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with ACADIA Pharmaceuticals and Cabaletta Bio

The main advantage of trading using opposite ACADIA Pharmaceuticals and Cabaletta Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACADIA Pharmaceuticals position performs unexpectedly, Cabaletta Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabaletta Bio will offset losses from the drop in Cabaletta Bio's long position.

The idea behind ACADIA Pharmaceuticals and Cabaletta Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.